Atyr Pharma Inc (ATYR)

Finanzdaten der Atyr Pharma Inc-Aktie (ATYR)

*Alle Zahlen in Millionen

Enddatum des Zeitraums	2026-06-30	2026-03-31	2025-12-31	2025-09-30	2025-06-30
Periodenlänge	3 Monate	3 Monate	3 Monate	3 Monate	3 Monate
	4.85%10.88	11.44	14.80	26.94	20.31
Research and Development	7.78%6.75	7.32	10.89	22.13	15.38
Operating Income/Loss	4.85%-10.88	-11.44	-14.80	-26.75	-20.31
Nonoperating Income/Loss	11.34%0.57	0.64	0.83	1.00	0.78
	4.47%-10.31	-10.79	-13.96	-25.75	-19.53
Attributable To Parent	4.47%-10.31	-10.79	-13.96	-25.74	-19.53
Attributable To Noncontrolling Interest	-0.00	-0.00	-0.00	-0.00	-0.00
Basic Average Shares	0.03%98.07	98.04	1.69	97.15	90.12
Diluted Average Shares	0.03%98.07	98.04	1.69	97.15	90.12
Basic Earnings Per Share	-0.11	-0.11	-0.14	-0.26	-0.22
Diluted Earnings Per Share	-0.11	-0.11	-0.14	-0.26	-0.22